OneTrust Launches Irish DPC Cookies Fast Track Program

ATLANTA, Aug. 11, 2020 /PRNewswire/ — OneTrust today announced the Irish DPC Cookies Fast Track Program, providing organizations with the resources needed to get up and running with cookie compliance before the Irish Data Protection Commission’s (DPC) October 5, 2020 deadline. These fast track resources will help organizations get same-day support and guidance to implement a cookie compliance solution according to DPC guidelines before the end of the grace period.

ATLANTA, Aug. 11, 2020 /PRNewswire/ — OneTrust today announced the Irish DPC Cookies Fast Track Program, providing organizations with the resources needed to get up and running with cookie compliance before the Irish Data Protection Commission’s (DPC) October 5, 2020 deadline. These fast track resources will help organizations get same-day support and guidance to implement a cookie compliance solution according to DPC guidelines before the end of the grace period.

Fast track your Irish DPC cookies implementation today with OneTrust

In April 2020, the DPC published updated guidance on the use of cookies and tracking technologies following an examination of their use on a range of different websites. In this report, the DPC noted there will be an increase in enforcement against non-compliant businesses beginning on October 5, 2020. The DPC’s key focuses for non-compliance include setting cookies based on implied consent, marketing and analytics cookies, and the inability to change or withdraw consent.

With OneTrust’s Irish Cookies Fast Track Program, organizations can fast track their cookie compliance with same-day access to a range of resources. With the October 5 deadline quickly approaching, OneTrust’s program will allow organizations to easily create, customize and publish their cookie banner and preference center to capture valid consent for cookies and block cookies and trackers from being deployed until that consent is given.

OneTrust’s Irish DPC Cookies Fast Track Program offers customers same-day access to:

  • Their OneTrust tenant
  • Step-by-step implementation guides and a range of resources
  • Implementation webinars and Q&A
  • Pre-configured cookie banner & preference center templates
  • 24/7 support

Fast track your Irish DPC cookies implementation today with OneTrust

«With the October 5 deadline fast approaching, we want to ensure our customers are ready and have the resources they need to be compliant with the DPC’s guidance on cookies and tracking technologies,» said Kabir Barday, OneTrust CEO and Fellow of Information Privacy (FIP). «With OneTrust’s Irish Cookies Fast Track Program, organizations can start their implementation same day and have access to key resources to implement a compliant program.»

Fast track your Irish DPC cookies implementation today with OneTrust. For additional information or to request a demo, visit OneTrust.com. 

About OneTrust 
OneTrust is the #1 most widely used technology platform to help organizations be more trusted, and operationalize privacy, security, data governance, and compliance programs. More than 6,000 customers, including half of the Fortune 500, use OneTrust to build integrated programs that comply with the CCPA, GDPR, LGPD, PDPA, ISO27001, and hundreds of the world’s privacy, security, and compliance frameworks.

The OneTrust platform is powered by the OneTrust Athena™ AI and robotic automation engine, and our offerings include:  

    • OneTrust Privacy – Privacy Management Software 
    • OneTrust PreferenceChoice™ – Consent and Preference Management Software 
    • OneTrust Vendorpedia™ – Third-Party Risk Management Software and Cyber Risk Exchange 
    • OneTrust GRC – Integrated Risk Management Software 
    • OneTrust DataDiscovery™ – AI-Powered Discovery and Classification 
    • OneTrust DataGovernance – Governance and Metadata Management 
    • OneTrust Ethics – Compliance and Ethics Software 
    • OneTrust DataGuidance™ – Regulatory Research Software 

To learn more, visit OneTrust.com or connect on LinkedIn, Twitter, and Facebook

Media Contact
Gabrielle Ferree
+1 770-294-4668
media@onetrust.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/onetrust-launches-irish-dpc-cookies-fast-track-program-301109776.html

SOURCE OneTrust

Conductiv™ Introduces Diversity Initiative, Helping Health Systems Increase Spending with Minority-Owned Suppliers to Stimulate Economy and Improve Population Health

WALNUT CREEK, Calif., Aug. 11, 2020 /PRNewswire-PRWeb/ — Conductiv™, the leading third-party spend optimization solutions provider, announced today an initiative to help healthcare providers better identify and increase their spend with local and minority-owned suppliers.

As local, minority-owned suppliers have struggled with the economic impact of COVID-19, and the public advocates for businesses that promote greater equality, Conductiv’s latest enhancement offers diverse suppliers an…

WALNUT CREEK, Calif., Aug. 11, 2020 /PRNewswire-PRWeb/ — Conductiv™, the leading third-party spend optimization solutions provider, announced today an initiative to help healthcare providers better identify and increase their spend with local and minority-owned suppliers.

As local, minority-owned suppliers have struggled with the economic impact of COVID-19, and the public advocates for businesses that promote greater equality, Conductiv’s latest enhancement offers diverse suppliers an effective and proven way to grow their businesses, while enabling providers to encourage and promote diversity with their third-party service providers.

«Healthcare providers are looking to support a more diverse and inclusive roster of suppliers—including community-led minority-, women- and veteran-owned businesses—but it can often be difficult to identify diverse suppliers with capabilities needed within the healthcare industry,» said Conductiv CEO Chris Gormley. «Recognizing both the importance and need for national change in this moment, we immediately deployed a team of developers to create technology enhancements that enable Conductiv’s members to increase their percentage of spend with diverse and local suppliers. Studies have shown that population health and economic performance are correlated and hold influence over social and environmental outcomes.»

Conductiv will anchor this initiative by adding diversity analytics to its integrated third-party services optimization suite—allowing for immediate visibility of Tier 1 and Tier 2 local and minority-owned supplier spending and new suppliers. Customers will have the ability to precisely measure their diverse supplier spending and efficiently evaluate and activate new contracts with carefully vetted local, minority-owned suppliers from one platform.

Conductiv will also add local and regional GPO contracts with vetted diverse suppliers and illuminate diverse supplier GPO contracting opportunities based on a healthcare organization’s historic spend. For minority-owned suppliers, working with Conductiv Contracts provides an opportunity to grow their businesses with regional and national healthcare providers. A member advisory committee will guide these collective efforts and investments.

«We’re committed to helping healthcare supply chains increase their diversity and inclusion efforts by connecting them to high-quality minority-owned suppliers,» Gormley added. «Our members have indicated their challenges in differentiating diverse spend and finding qualified diverse suppliers. To solve these challenges, our team is building off Conductiv’s category-defining integrated purchased services optimization suite and strengthening our data sources to ensure this is a simple and advantageous feature for both healthcare providers and diverse suppliers.»

For more information, please visit Conductiv.com.

About Conductiv
ConductivTM, formerly Medpricer, empowers supply chains to optimize their third-party services. As the only end-to-end third-party lifecycle improvement company, ConductivTM shares its strategic sourcing expertise and category best practices with multiple industries including healthcare, hospitality, government, real estate, transportation and education. The company has led more than 700 bids for more than 120 organizations, exceeding $4 billion in contracted value. Member projects have generated $800 million of documented savings or an average savings value of 24% to date. To learn how supply chains are transforming their savings strategy, visit Conductiv.com.

###

 

SOURCE Conductiv

Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World

NEW YORK, Aug. 11, 2020 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it is launching a Named Patient Program for its non-opioid bone metastases pain palliation drug, Strontium89 (Strontium Chloride Sr-89 Injection, USP). The Named Patient Program will be available to physicians…

NEW YORK, Aug. 11, 2020 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it is launching a Named Patient Program for its non-opioid bone metastases pain palliation drug, Strontium89 (Strontium Chloride Sr-89 Injection, USP). The Named Patient Program will be available to physicians and patients in the EU and throughout the world, and will be facilitated by Caligor Coghlan Pharma Services (CCPS).

Strontium89 is an FDA-approved, non-opioid radiopharmaceutical indicated for the treatment of painful skeletal metastases caused by cancer, and is agnostic of the primary tumor. Common primary tumors that metastasize to the bone include prostate, breast, lung, as well as others. In several multicenter, placebo-controlled trials in cancer patients with pain from bone metastases, pain relief occurred in more patients treated with a single injection of Strontium89 than in patients treated with an injection of placebo. Strontium89 is administered intravenously once every three months and for some patients can reduce or even eliminate the need for opioid analgesics; pain relief lasts from 2 – 5 months in most patients.

Use of Strontium89 in patients with evidence of seriously compromised bone marrow from previous therapy or disease infiltration is not recommended unless the potential benefit of the treatment outweighs its risks. Bone marrow toxicity is to be expected, particularly in white blood cells and platelets. The extent of toxicity is variable but effects are generally transient. In randomized studies of Strontium89, the majority of hematologic toxicity was mild to moderate (Grade 2 or less) and white blood cell and platelet counts remained within approximately 70% of pretreatment levels. For more information including Important Safety Information please visit the Strontium89 page on Qbiomed.com.

Over ten million people around the world suffer from pain associated with metastatic cancer in the bone and may benefit from Strontium89. For nearly two years, there has been little to no access to this vital therapy, after manufacturing ceased in December of 2018. Q BioMed is pleased that the Named Patient Program will ensure immediate global patient access to an important therapy for this patient population. In the meantime, Q BioMed is actively pursuing full regulatory and marketing approval for Strontium89 in all major markets worldwide.

Denis Corin, CEO of Q BioMed, said of the program, «We are very happy that Strontium89 is once again available worldwide, and that physicians have the ability to prescribe a safe, effective and non-opioid treatment to their bone metastasis pain patients regardless of their primary tumor type and notably beyond prostate cancer. We are actively working to ensure that Strontium89 is accessible to patients everywhere and to extend its relevance and use thorough additional clinical study.»

Any queries about the program and availability can be directed to info@qbiomed.com and at https://qbiomed.com/pipeline/sr89.

About Q BioMed Inc.

Q BioMed Inc is a biotech acceleration and commercial stage company. Q BioMed is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support, and expansion capital needed to ensure they meet their developmental potential, enabling them to provide products to patients in need‏.

Please visit http://www.QBioMed.com and sign up for regular updates.

Media Contact Q BioMed:
Denis Corin
CEO

Investor Relations
+1(404) 995-6671
ir@qbiomed.com

About CCPS 

Caligor Coghlan Pharma Services is a global company focused on changing the healthcare paradigm by supporting medical device and pharmaceutical companies from concept to commercialisation. Providing bespoke development consulting, regulatory and strategic services, packaging and labelling for clinical trial and initial commercial launch, early access and compassionate use programs, and medication/product management, storage, and logistics for hospitals, pharmacies and global healthcare systems. Ensuring patients have access to life enhancing treatments worldwide.

Forward-Looking Statements:

This press release may contain «forward-looking statements» within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Please visit http://www.QBioMed.com and sign up for regular updates.

 

Cision View original content:http://www.prnewswire.com/news-releases/q-biomed-announces-strontium89-will-be-available-as-of-september-2020-through-named-patient-program-for-bone-metastases-pain-palliation-in-eu-and-rest-of-world-301109633.html

SOURCE Q BioMed Inc.

SCAN Health Plan Leverages AI Based Predictive Models to Improve Identification of High Risk Members

LONG BEACH, Calif., Aug. 11, 2020 /PRNewswire/ — SCAN Health Plan®, one of the nation’s largest not-for-profit Medicare Advantage health plans, today announced the first phase launch of artificial intelligence (AI) based predictive models designed to improve health outcomes and inform benefit and service…

LONG BEACH, Calif., Aug. 11, 2020 /PRNewswire/ — SCAN Health Plan®, one of the nation’s largest not-for-profit Medicare Advantage health plans, today announced the first phase launch of artificial intelligence (AI) based predictive models designed to improve health outcomes and inform benefit and service design. This implementation will improve SCAN’s ability to identify high-needs members and provide tailored interventions to help avoid or reduce hospitalizations.

«At SCAN our goal is to support our members at every stage of their journey and utilizing advanced technology, such as AI, enables us to do so on a much more proactive basis,» said Josh Goode, SCAN chief information officer. «As our members’ needs evolve, the KenSci platform allows us to better interpret the needs behind the data so that we can respond with programs and services to help keep them healthy and independent.»

As a part of the first phase implementation, SCAN and KenSci, a system of intelligence for healthcare, have launched explainable AI models for healthcare, enabling SCAN to identify members at risk of Hospitalization for Potentially Preventable Complications* (HPC) as well as those eligible for Nursing Facility Level of Care (NFLOC). The platform provides SCAN with insights, proactively identifying members potentially at risk for specific disease states allowing for early interventions. In addition, SCAN is using machine learning (ML) techniques that are routine across consumer applications but new to healthcare in helping identify gaps in care to improve the management of chronic conditions.

«The volume and veracity of data opens up immense possibilities for healthcare organizations to transform the way they support their plan members,» said Samir Manjure, co-founder & CEO, KenSci. «We are excited to work with SCAN and appreciate their expertise in developing these tools to meet the needs of seniors. Together, there is tremendous opportunity to impact the health of older adults.»

«Data is a critical asset in modern healthcare and harnessing it appropriately provides invaluable insight,» said Moon Leung, SCAN senior vice president and chief informatics officer. «By leveraging KenSci’s AI expertise, we believe we can utilize our data to improve health outcomes and quality of life for many of our members.»

*HPC measure is based on National Committee for Quality Assurance (NCQA) HEDIS® technical specifications. For more details, please visit ncqa.org

About SCAN Health Plan
SCAN Health Plan is one of the nation’s largest not-for-profit Medicare Advantage plans, serving more than 220,000 members in California. Since its founding in 1977, SCAN has been a mission-driven organization dedicated to keeping seniors healthy and independent. Independence at Home, a SCAN community service, provides vitally needed services and support to seniors and their caregivers. SCAN also offers education programs, community funding, volunteer opportunities and other community services throughout our California service area. To learn more, visit scanhealthplan.com or facebook.com/scanhealthplan or follow us on Twitter @scanhealthplan.

About KenSci
KenSci’s machine learning powered risk prediction platform helps healthcare providers and payers intervene early by identifying clinical, financial and operational risk to save costs and lives. KenSci’s platform is engineered to ingest, transform and integrate healthcare data across clinical, claims, and patient generated sources. With a library of pre-built models and modular solutions, KenSci’s machine learning platform to integrates into existing workflows allowing health systems to better identify utilization, variation and improve hospital operations. With Explainable AI models for healthcare, KenSci is making risk-based prediction more efficient and accountable.

KenSci was incubated at University of Washington’s Center for Data Science at UW Tacoma and designed on the cloud with help from Microsoft’s Azure4Research grant program. KenSci is headquartered in Seattle, with offices in Singapore and Hyderabad. For more information, visit www.kensci.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/scan-health-plan-leverages-ai-based-predictive-models-to-improve-identification-of-high-risk-members-301108271.html

SOURCE SCAN Health Plan

MagVenture receives FDA clearance for OCD

ALPHARETTA, GA, Aug. 11, 2020 /PRNewswire/ — FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks the second indication in the US for the Danish medical device company MagVenture who is already FDA cleared for the treatment of major depressive disorder.

OCD is a mental health disorder characterized by unreasonable thoughts and fears (obsessions) which lead to repetitive behavior…

ALPHARETTA, GA, Aug. 11, 2020 /PRNewswire/ — FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks the second indication in the US for the Danish medical device company MagVenture who is already FDA cleared for the treatment of major depressive disorder.

OCD is a mental health disorder characterized by unreasonable thoughts and fears (obsessions) which lead to repetitive behavior (compulsions). OCD can severely affect one’s daily life and routines and cause distress or even functional impairment. Although pharmaceutical and psychological interventions are available, some OCD patients experience limited results from these and need more therapeutic options.

Transcranial Magnetic Stimulation (TMS) uses magnetic pulses to stimulate a specific area in the brain in order to improve the OCD symptoms. TMS is a well-established, FDA cleared option for people suffering from treatment-resistant Major Depressive Disorder and available throughout the US at numerous psychiatric practices and hospitals. MagVenture TMS Therapy® was FDA cleared for depression in 2015 and the first company to receive FDA clearance for the 3-minute Express TMS® – the shortest TMS treatment currently available. 

MagVenture TMS Therapy is an adjunct treatment to existing OCD therapies which may involve pharmaceutical and behavioral therapy. It is an out-patient procedure with no systemic side effects. The treatment specifically targets the networks in the brain which are known to be particularly affected by OCD, including the deeper-lying structures.

«We have worked closely with brain researchers for well over 25 years, providing numerous TMS solutions to help advance the field of neuroscience – both basic and applied. Expanding the treatment options to include other indications than major depressive disorder, such as OCD, is one more important step towards helping more adult patients improve their mental health,» says VP of Sales, MagVenture Inc, Kerry Rome.   

MagVenture TMS Therapy® FDA clearances: «As an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD)» and «Treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.» 

MagVenture is a Danish medical device company specializing in non-invasive magnetic stimulation systems for the treatment of major depressive disorder and brain research. In 2018, MagVenture was the first TMS company to receive FDA clearance for Express TMS®, reducing treatment time from the standard 37 minutes to just 3 minutes per session.

Kerry Rome, Vice President Sales, MagVenture Inc., USA: +1-310-213-2697

 

Cision View original content:http://www.prnewswire.com/news-releases/magventure-receives-fda-clearance-for-ocd-301109815.html

SOURCE MagVenture

Constellation HomeBuilder Systems Rolls Out New COVID-19 Screening Tool

TORONTO, Aug. 11, 2020 /PRNewswire/ — Employees are one of a company’s greatest assets. Providing them peace of mind and protecting their health and safety has always been our first priority. With these beliefs in mind, Constellation HomeBuilder Systems is proud to announce the launch of our new <a target="_blank"…

TORONTO, Aug. 11, 2020 /PRNewswire/ — Employees are one of a company’s greatest assets. Providing them peace of mind and protecting their health and safety has always been our first priority. With these beliefs in mind, Constellation HomeBuilder Systems is proud to announce the launch of our new COVID-19 Screening Tool. As more states mandate health pre-screenings, there’s no better time to mitigate the risk to our clients’ operations.

As the largest provider of home building software solutions and services, Constellation HomeBuilder Systems is ideally placed to offer this unique solution that supports business operations, while minimizing risk for your staff and stakeholders.

Our COVID-19 Screening Tool has been developed specifically for the home building industry, and allows managers and HR teams to quickly and easily execute digital health assessments that are both secure and confidential.

Through the tool, assessment questionnaires are sent to anyone who plans to enter your workplace each day. This assessment includes specific questions suggested by health experts, or businesses can implement their own. This helps to ensure compliance with governmental as well as industry regulations.

Robust and customizable reporting features offer regular updates, so management has all the information they’ll need to make informed decisions, protect their business’s ongoing work, and minimize risk for their team.

Inside the tool, guidelines on COVID-19 safety protocols, self-isolation after exposure, and testing make it easy for your team to find accurate and up-to-date health information at any time of the day or night.

«Our primary goal is for our solutions to serve our clients, and help them recover from the devastating impacts of COVID-19,» says Christian Caswell, Director and Founder of CustomerInsight at Constellation HomeBuilder Systems. «Our new COVID-19 Screening Tool is a practical way for us to help our partners by offering a simple solution for new provincially-mandated health screening requirements.»

Since rolling out the COVID-19 Screening Tool from CustomerInsight, Constellation HomeBuilder Systems has continually invested in ongoing customer support and updates that ensure this tool can be integrated into any business’s existing systems. Click here to find more information on using the COVID-19 Screening Tool for your business.  

About Constellation HomeBuilder Systems
Constellation HomeBuilder Systems is the largest provider of software and services in the building industry. Their innovative software solutions, available as standalone or integrated systems, empower builders with information to drive business objectives and simplify the process of building homes and condos. Constellation HomeBuilder Systems is the home building software division of Constellation Software Inc. an international provider of market-leading software and services for specialized industries, which is traded publicly on the Toronto Stock Exchange.

For more information, please contact:

Elmira Abushayeva
Director of Marketing, Constellation HomeBuilder Systems
888-723-2222
eabushayeva@constellationhb.com

Cision View original content:http://www.prnewswire.com/news-releases/constellation-homebuilder-systems-rolls-out-new-covid-19-screening-tool-301109705.html

SOURCE Constellation HomeBuilder Systems

New Center for Migration and Economic Stabilization Launched by Creative Associates International

WASHINGTON, Aug. 11, 2020 /PRNewswire/ — Creative Associates International is launching a specialized Center for Migration and Economic Stabilization to drive innovation and program responsiveness to this global phenomenon.

«Our launch is timely since the pandemic has generated new urgencies around migration,» says Creative President and CEO <a target="_blank"…

WASHINGTON, Aug. 11, 2020 /PRNewswire/ — Creative Associates International is launching a specialized Center for Migration and Economic Stabilization to drive innovation and program responsiveness to this global phenomenon.

«Our launch is timely since the pandemic has generated new urgencies around migration,» says Creative President and CEO Leland Kruvant. «This Center will combine technical rigor and ingenuity with Creative’s on-the-ground programmatic experience to address the pressing challenges that lure migrants into risking it all.»

The Center for Migration and Economic Stabilization builds on Creative’s 2019 groundbreaking research on the drivers of migration from Central America’s Northern Triangle.  

Pablo Maldonado, Creative’s Chief Operating Officer, says those motivations to migrate North remain as present as ever and will combine with the effects of COVID-19 to generate a powerful impetus to migrate.

«Migration is connected and overlaps with other systemic challenges facing Central America, West Africa and elsewhere,» Maldonado says. «Unfortunately, long-standing development challenges will intersect with the economic hardship of COVID-19 to create a perfect storm for migration. We will see shifts in migration activity and trends, including changing attitudes, internal migration and relocations across borders all caused by the economic squeeze.»

The Center for Migration and Economic Stabilization will serve as a hub of thought leadership on the issue both as a cause and byproduct of other development challenges challenges. The Center has a pointed focus on serving the underserved, those who are not typically touched by more traditional economic development, including youth, women and those working in informal economies.

The Center will continue and expand on Creative’s earlier migration pursuits, including methodical data gathering to track migration and its drivers, demystification of popular migration beliefs that are not supported by evidence and, more broadly, the creation of programs that are material to the decision to migrate — mostly in the economic arena, Maldonado says. 

«The Center will help us stay at the forefront of understanding these issues and ultimately lead to better, locally focused programming to mitigate the causes of migration. It will be a much-needed resource for fresh thinking on migration,» Maldonado says. 

Thought leader, practitioner to direct the Center 

The Center for Migration and Economic Stabilization is led by noted expert Manuel Orozco, Ph.D., who joined Creative after more than 20 years at the Inter-American Dialogue in Washington, D.C. 

Orozco, a recognized researcher and analyst of global migration flows, including remittances, will complement Creative’s technical expertise in economic growth, youth, education, governance, citizen security and more to enrich programming and identify opportunities to respond thoughtfully to migration.  

Most recently Senior Director of Remittances and Development at the Inter-American Dialogue, Orozco also led Creative’s 2019 study into the drivers of migration from Honduras, El Salvador and Guatemala. Details may be seen at: https://www.saliendo-adelante.com 

«After getting to know Creative’s high-caliber work and its dedication to fully understanding the causes of migration, I’m honored by the opportunity to join the team and help Creative continue being a leader on this global topic,» Orozco says. «Through the Center, I hope to provide valuable insights to ensure that Creative’s programs help mitigate the causes of migration.»  

The need for additional expertise and leadership on migration became more urgent as COVID-19 spread across the globe, leaving already fragile communities reeling and indicating a major impact on migration patterns for years to come.  

«We know that COVID-19 will have a profound effect on migration,» Maldonado says. «With the creation of the Center for Migration and Economic Stabilization, we can meet this looming challenge and better serve communities and families grappling with the fallout of the pandemic.»  

Orozco will convene a panel on COVID-19 and remittances at this year’s virtual Central America Donors Forum. Click here for more information and to register.  

In addition to his new role at Creative, Orozco is a Senior Migration Fellow for the Center for International Development at Harvard University and Senior Migration and Remittances Advisor for the International Fund for Agricultural Development. He holds a Ph.D. in political science from the University of Texas at Austin, an M.A. in public administration and Latin American studies, and a B.A. in international relations from the National University of Costa Rica.

ABOUT CREATIVE ASSOCIATES INTERNATIONAL

Creative Associates International works with underserved communities by sharing expertise and experience in education, elections, economic growth, governance and transitions from conflict to peace.

Creative has grown to become one of the leaders among the U.S. private sector implementers of global development projects. Creative is minority owned and operated. 

To learn more about Creative Associates International, please visit: http://www.CreativeAssociatesInternational.com 

Contact: Michael J. Zamba, communications@creativedc.com

Related Images

family-in-san-pedro-sula-honduras.jpg
Family in San Pedro Sula, Honduras
A woman who previously attempted to migrate to the United States walks with her family outside of their home in Honduras.

Related Links

Creative Associates International

Saliendo Adelante: Why migrants risk it all

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/new-center-for-migration-and-economic-stabilization-launched-by-creative-associates-international-301109216.html

SOURCE Creative Associates International

Ashland University MBA to Offer Virtual International Study Tours

ASHLAND, Ohio, Aug. 11, 2020 /PRNewswire/ — Ashland University MBA Program announces the participation of virtual study tours in partnership with <a target="_blank"…

ASHLAND, Ohio, Aug. 11, 2020 /PRNewswire/ — Ashland University MBA Program announces the participation of virtual study tours in partnership with International Study Programs (ISP), being the first Ohio MBA Program to offer this opportunity. In these unprecedented times, Ashland University is adapting and innovating to continue to provide MBA students with world-class opportunities.  

The virtual study tour provides students with a best-in-class consulting experience, engaging with a world-renowned organization. Students attend virtual meetings with key leaders and stakeholders of Fortune 500 companies to present new strategies and solutions based on today’s challenges. 

Global experience is invaluable to the student learning of MBA students, offering alternative opportunities to international study tours is at the forefront of the Ashland University College of Business and Economics Dean, Dr. Elad Granot’s mind. «Our MBA programs strive to provide the most valuable experiences available to our students. Due to the impact of COVID-19, we worked diligently to provide an alternative that would provide the same education and exposure as our world-class international study tours. We are proud to be the first University in Ohio to offer this solution and plan to continue to offer unique and experiential experiences to our students.»

This fall, Ashland MBA students will experience Prague. Seeing the country through the lens of guided tours and cultural excursions including: city-tours, local cultural immersion and a local cooking experience. Students will expand their professional network by consulting with Oracle to bridge the physical and digital world. 

ABOUT ASHLAND UNIVERSITY MBA PROGRAMS 
The Ashland University MBA Program has been fully accredited by the Accreditation Council for Business Schools and Programs (ACBSP) for more than 20 years. This distinction supports Ashland’s commitment to a student-centered teaching and learning approach. For more information on the Ashland University MBA Programs, click here.

MEDIA CONTACT 

For information on the tour, MBA programs, or those interested in applying, please contact Ron Mickler at (419) 289-5214 or rmickler@ashland.edu

For interview opportunities please contact Alyssa Galik at VividFront at (440) 429-5509 or agalik@vividfront.com.   

Related Images

prague-virtual-tour.jpg
Prague Virtual Tour
Ashland University MBA will offer world-class virtual study tours to students.

Related Links

Prague Virtual Tour Details

Ashland University MBA Programs

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ashland-university-mba-to-offer-virtual-international-study-tours-301109599.html

SOURCE Ashland University

State of Sustainable Fleets Report Released, Finds Sustainable Vehicle Technologies and Fuels Are Growing Across All Sectors

SANTA MONICA, Calif., Aug. 11, 2020 /PRNewswire/ — Clean technology consulting firm and producers of the annual Advanced Clean Transportation (ACT) Expo, Gladstein, Neandross & Associates (GNA) has authored and launched the first comprehensive, technology-neutral industry report that examines the…

SANTA MONICA, Calif., Aug. 11, 2020 /PRNewswire/ — Clean technology consulting firm and producers of the annual Advanced Clean Transportation (ACT) Expo, Gladstein, Neandross & Associates (GNA) has authored and launched the first comprehensive, technology-neutral industry report that examines the current state of prevalent sustainable vehicle platforms for medium- and heavy-duty fleets and identifies the trends shaping the future of the industry.

Produced with support from the report’s title sponsors Daimler Trucks North America, Penske Transportation Solutions, Shell Oil Company, and supporting sponsor Exelon Corporation, the report offers insights into the current and future adoption of four sustainable fuel and vehicle technologies: natural gas vehicles (NGVs), propane (LPG) vehicles, battery electric vehicles (BEVs), hydrogen fuel cell electric vehicles (FCEVs). As fleets adopt these technologies, they are inevitably compared to baseline diesel and gasoline vehicles, which have historically—and will continue to—dominate the commercial fleet market. This report also summarizes sustainability trends in these baseline technologies that serve as a benchmark for emerging alternative fuel vehicles and advanced technologies.

The debut report finds that while diesel and gasoline vehicles have led the medium- and heavy-duty fleet markets in terms of vehicle and fuel sales for decades, fleets are now testing and purchasing sustainable vehicle technologies in record numbers. The authors note the industry is experiencing a critical inflection point where alternative fuel vehicle adoption is expanding from the gradual uptake in niche applications seen over the past several decades, to faster and broader adoption within the last few years, supported by four key findings:

  • Across a broad spectrum of fleets surveyed, approximately 98% expect to increase or continue the same level of use of sustainable vehicle technologies and fuels.
  • Natural gas, propane, battery electric, and hydrogen fuel cell electric vehicles, the four sustainable vehicle technology platforms covered in the study, are all growing in terms of vehicle sales, fuel sales, and investment.
  • Sustainability is the top motivator for purchasing decisions among early adopter public, private, and even for-hire fleets in deploying clean vehicle technologies. Many U.S. fleets are now transitioning to clean vehicle technologies not just to reduce total cost of ownership but to meet sustainability objectives.
  • Fleets confirm there is no material performance loss when switching to most renewable fuelsrenewable diesel, natural gas, and electricity—and would use more when it is a cost-neutral, drop-in replacement.

«We applaud the research effort and insights presented by the inaugural State of Sustainable Fleets report,» said Richard Howard, senior vice president, On-highway sales and marketing for DTNA. «Our vision for a future of C0₂-neutral commercial transportation can only be realized by the collaboration between manufacturers and fleets to ensure we are delivering solutions to meet their needs. We are pursuing clean technologies of the future, and we will arrive to that future together as an industry who keeps the world moving.»     

«We are very pleased to serve as a sponsor of the inaugural State of Sustainable Fleets Report,» stated Drew Cullen, senior vice president of fuels and facility services for Penske Transportation Solutions. «We are here to advise and support our customers in navigating the complexities of operating and managing the latest vehicle technologies as they seek to reach their sustainability goals.»

«As one of the largest providers of fleet solutions globally, we support our customers in their transition to lower-emission fuels through energy provision coupled with expertise in road services and fleet management. This report is a concise and comprehensive resource, equipping fleet managers with critical insights they need to plan for operations in a lower-emission world,» said Giorgio Delpiano, vice president of fleet solutions for Shell.

«Exelon is committed to providing a cleaner and brighter future for our customers and communities while achieving excellent operational performance,» said Calvin Butler, CEO of Exelon Utilities. «Transportation electrification holds the promise of helping the cities and states in which we operate meet their environmental goals, reduce their carbon footprint, bring cleaner air to all communities we serve and create economic opportunity through job creation and reduced energy costs. At Exelon, we recently announced our commitment to electrify 50 percent of our utility vehicle fleet by 2030, and we understand the importance of selecting the right sustainable technology and designing, building and implementing the necessary infrastructure. Fleets across the U.S. rely on industry resources like the State of Sustainable Fleets report to make informed decisions as they transition to clean fuels and technology.»

Through interviews and surveys, the report gathers data from stakeholders who have real-world experience deploying sustainable vehicle technologies, including progressive fleet owners and operators, original equipment manufacturers (OEMs), and infrastructure providers. The analysis includes public, private, and for-hire fleets, including school, municipal/shuttle, urban delivery, refuse, utility, transit, short-haul, and long-haul sectors. This first-of-its-kind report includes unique insights into vehicle sale trends, anticipated vehicle development timelines, real-world infrastructure and fuel costs, and the growing adoption of renewable fuels. 

Structured to cover each of the sustainable vehicle technologies in depth, the report is organized such that each chapter is a standalone guide to the current state and future trends of that technology with detailed data, analysis, and unique insights.

GNA is hosting a complimentary two-part virtual launch event to share the report’s key findings in partnership with ACT Virtual, a digital extension of the annual ACT Expo. On Tuesday, August 11th at 10 a.m. PST executives from the report’s title sponsors will discuss the report’s findings. Panelists included:

  • Brian Cota, vice president of sales for national accounts for Daimler Trucks North America
  • Drew Cullen, senior vice president of fuels and facility services for Penske Transportation Solutions
  • Giorgio Delpiano, vice president of fleet solutions for Shell Oil Company
  • Erik Neandross, chief executive officer for Gladstein, Neandross & Associates (GNA) will moderate the discussion

Representatives from leading fleets will join a follow-up panel, the State of Sustainable Fleets in a COVID-19 World on Thursday, August 13th at 10 a.m. PST. Panelists include:

  • Carlton Rose, president of global fleet maintenance and engineering for UPS
  • James Cade, vice president of fleet services for Ruan Transportation
  • Darryl Spencer, senior assistant vice president of engineering for Dallas Area Rapid Transit (DART)
  • Drew Cullen, senior vice president of fuels and facility services for Penske Transportation Solutions will moderate the discussion

For more information about the report and the launch event series, visit http://www.stateofsustainablefleets.com/.

About Gladstein, Neandross & Associates (GNA)

GNA is a North American consulting firm specializing in the development and commercialization of renewable energy technologies, near-zero and zero emission vehicles, and low carbon fuels for transportation and commercial use. GNA’s core expertise is providing strategic support to develop and bring technologies to market, managing relationships with key public agencies, grant writing and administration, as well as implementing effective outreach, communication, and education programs. www.gladstein.org 

About Daimler Trucks North America

Daimler Trucks North America LLC, headquartered in Portland, Oregon, is the leading heavy-duty truck manufacturer in North America. Daimler Trucks North America produces and markets commercial vehicles under the Freightliner, Western Star and Thomas Built Buses nameplates. Daimler Trucks North America is a Daimler company, the world’s leading commercial vehicle manufacturer.

About Penske Transportation Solutions

Penske Transportation Solutions is the umbrella brand for Penske Truck Leasing, Penske Logistics, Epes Transport Systems and Penske Vehicle Services. Our businesses provide innovative transportation, supply chain and technology solutions to keep the world moving forward. Visit www.GoPenske.com to learn more.

About Shell Oil Company

Shell Oil Company is an affiliate of the Royal Dutch Shell plc, a global group of energy and petrochemical companies with operations in more than 70 countries. In the U.S., Shell operates in 50 states and employs more than 17,000 people working to help tackle the challenges of the new energy future.

About Exelon

Exelon Corporation is a Fortune 100 energy company with the largest number of electricity and natural gas customers in the U.S. Exelon does business in 48 states, the District of Columbia and Canada and had 2019 revenue of $34 billion. Exelon serves approximately 10 million customers in Delaware, the District of Columbia, Illinois, Maryland, New Jersey and Pennsylvania through its Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO and Pepco subsidiaries. Exelon is one of the largest competitive U.S. power generators, with more than 31,000 megawatts of nuclear, gas, wind, solar and hydroelectric generating capacity comprising one of the nation’s cleanest and lowest-cost power generation fleets. The company’s Constellation business unit provides energy products and services to approximately 2 million residential, public sector and business customers, including three fourths of the Fortune 100. Follow Exelon on Twitter @Exelon.

FOR INFORMATION:
Celeste Griffy
Gladstein, Neandross & Associates
424.744.4489
celeste.griffy@gladstein.org

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/state-of-sustainable-fleets-report-released-finds-sustainable-vehicle-technologies-and-fuels-are-growing-across-all-sectors-301109539.html

SOURCE Penske Transportation Solutions

LegalRideshare Provides Drivers With Key Action Steps to Take Within 24 Hours of a Rideshare Accident

CHICAGO, Aug. 11, 2020 /PRNewswire/ — With the demand for ridesharing services having surged over the first half of the summer season, drivers have been steadily increasing their number of hours on the road. According to data analyzed by

CHICAGO, Aug. 11, 2020 /PRNewswire/ — With the demand for ridesharing services having surged over the first half of the summer season, drivers have been steadily increasing their number of hours on the road. According to data analyzed by LegalRideshare, both drivers and riders should be aware of the proper steps to take after a rideshare accident. One small misstep can be the difference between a successful insurance claim and financial disaster.

These steps include: 

  • Ensure the Safety of All Passengers: Verbally confirm the safety of passengers to ensure that they have not experienced any major injuries as a result of the accident. 
     
  • Obtain Passenger Information: In the event of an accident, it is crucial for drivers to collect passenger information for any future legal processes. These individuals are witnesses to the crash and can confirm the sequence of events that occurred before, during, and after the accident. Drivers should be swift and considerate in their attempts to acquire contact information from their passengers, as these individuals may play a major role in the legal proceedings that take place in the weeks or months following the accident. The rideshare companies often will not divulge contact information after the fact.
     
  • Call the Police: Call the local police department to file a police report. This report should include the series of events that resulted in the accident, the positions of the cars involved, and the actions and statements of any other individuals involved in the incident. It is important to be as clear and concise as possible, as the driver’s communication of the sequence of events will ultimately help determine the facts of the case. 
     
  • Seek Medical Attention: Drivers who get into accidents and lack health insurance may be hesitant to seek medical treatment due to financial constraints. Law firms like LegalRideshare can assist drivers in locating doctors who treat patients without medical insurance. These contacts allow the injured person to get the treatment they need, without facing a significant financial burden. 

«One of the biggest mistakes people make after a crash is failing to seek timely medical treatment,» said Bryant Greening, an attorney and co-founder of LegalRideshare. «Long gaps between the date of an accident and medical care are devastating to bodily injury insurance claims. It allows the insurance company to argue the accident did not cause the injury.» 

As the leading law firm for gig economy workers, LegalRideshare has secured millions of dollars for injured drivers, passengers, and victims. The firm serves as a national voice on gig economy law, policy and safety issues, having been featured in The New York Times, The Wall Street Journal, The Washington Post, CNN, and many other national media outlets. 

To learn more about how the LegalRideshare team can provide important information or legal representation regarding ridesharing accidents, please visit its website.

About LegalRideshare

LegalRideshare is the first law firm in the United States to focus exclusively on Uber®, Lyft®, and gig economy accidents and injuries.

Since its inception, LegalRideshare has grown into a national brand. Its lawyers are the go-to source on rideshare-related issues, serving hundreds of clients and securing millions of dollars for injured drivers and passengers. Follow LegalRideshare on Twitter and Facebook.

Media Contact:
Kirsten Quiles
kirsten@newswire.com

Related Images

legalrideshare-provides-drivers.png
LegalRideshare Provides Drivers With Key Action Steps to Take Within 24 Hours of a Rideshare Accident

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/legalrideshare-provides-drivers-with-key-action-steps-to-take-within-24-hours-of-a-rideshare-accident-301109686.html

SOURCE LegalRideshare